Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
2
×
clinical trials
2
×
life sciences
national blog main
new york blog main
alirocumab
alnylam pharmaceuticals
amgen
boston
boston top stories
cancer
codiak biosciences
cutaneous t-cell lymphoma
drugs
evercore isi
evolocumab
exosome
heart attack
inclisiran
jazz pharmaceuticals
joseph swartz
medicines co.
new york
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
sarepta therapeutics
stroke
svb leerink
umer raffat
What
based
2
×
medicines
new
alnylam
begin
biosciences
bio’s
brings
bubbles
cells
cholesterol
class
clinical
codiak
data
drug
evidence
exosome
exosomes
formed
fund
heart
ipo
lasting
long
looms
lowering
medco
million
partner
pharmaceuticals
presented
reckoning
rna
supporting
term
tests
tiny
touts
trials
Language
unset
Current search:
xconomy.com
×
based
×
" boston blog main "
×
" clinical trials "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
